Skip to main content
VCbacked
Log inGet Started

Francis Medical

Maple Grove, United States

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

$80.0M raised
Jan 2025
Series C
Medical

Top Investors

Arboretum VenturesSolas BioVenturesColoplastOrlando Health VenturesTonkawa Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Francis Medical

How much funding has Francis Medical raised?
Francis Medical has raised $80.0M in total funding. The most recent round was Series C. The last funding was announced in January 2025.
Who are Francis Medical's investors?
Francis Medical's investors include Arboretum Ventures, Solas BioVentures, Coloplast, Orlando Health Ventures, Tonkawa Investments.
Where is Francis Medical headquartered?
Francis Medical is headquartered in Maple Grove, United States.
What does Francis Medical do?
Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.
What stage is Francis Medical at?
Francis Medical is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Francis Medical — Funding & Investors." VCBacked, January 7, 2025, https://www.vcbacked.co/company/francis-medical. Accessed June 17, 2026.
APA
VCBacked. (2025). Francis Medical — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/francis-medical
Wikipedia (cite web)
{{cite web |title=Francis Medical — Funding & Investors |url=https://www.vcbacked.co/company/francis-medical |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Medical

View all
Tempus
Chicago
Sedivention
Munich$848K
Anagram Therapeutics
Boston
ParcelBio
San Francisco$13.2M
LTZ Therapeutics
San Francisco$40.0M
Autoimmunity BioSolutions
Houston$2.0M